624 related articles for article (PubMed ID: 25733633)
1. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Mähler A; Steiniger J; Bock M; Klug L; Parreidt N; Lorenz M; Zimmermann BF; Krannich A; Paul F; Boschmann M
Am J Clin Nutr; 2015 Mar; 101(3):487-95. PubMed ID: 25733633
[TBL] [Abstract][Full Text] [Related]
2. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE
Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.
Bellmann-Strobl J; Paul F; Wuerfel J; Dörr J; Infante-Duarte C; Heidrich E; Körtgen B; Brandt A; Pfüller C; Radbruch H; Rust R; Siffrin V; Aktas O; Heesen C; Faiss J; Hoffmann F; Lorenz M; Zimmermann B; Groppa S; Wernecke KD; Zipp F
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33762428
[TBL] [Abstract][Full Text] [Related]
4. Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects.
Most J; Goossens GH; Jocken JW; Blaak EE
Int J Obes (Lond); 2014 May; 38(5):698-706. PubMed ID: 24317366
[TBL] [Abstract][Full Text] [Related]
5. A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects.
Most J; van Can JG; van Dijk JW; Goossens GH; Jocken J; Hospers JJ; Bendik I; Blaak EE
Sci Rep; 2015 Dec; 5():17896. PubMed ID: 26647963
[TBL] [Abstract][Full Text] [Related]
6. Acute Epigallocatechin-3-Gallate Supplementation Alters Postprandial Lipids after a Fast-Food Meal in Healthy Young Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
de Morais Junior AC; Schincaglia RM; Passarelli M; Pimentel GD; Mota JF
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825556
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I
Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662
[TBL] [Abstract][Full Text] [Related]
8. Is metabolic flexibility altered in multiple sclerosis patients?
Mähler A; Steiniger J; Bock M; Brandt AU; Haas V; Boschmann M; Paul F
PLoS One; 2012; 7(8):e43675. PubMed ID: 22952735
[TBL] [Abstract][Full Text] [Related]
9. Physiological effects of epigallocatechin-3-gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: A systematic review and meta-analysis.
Kapoor MP; Sugita M; Fukuzawa Y; Okubo T
J Nutr Biochem; 2017 May; 43():1-10. PubMed ID: 27883924
[TBL] [Abstract][Full Text] [Related]
10. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study.
Boschmann M; Thielecke F
J Am Coll Nutr; 2007 Aug; 26(4):389S-395S. PubMed ID: 17906192
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients.
Platero JL; Cuerda-Ballester M; Ibáñez V; Sancho D; Lopez-Rodríguez MM; Drehmer E; Ortí JER
Nutrients; 2020 Jan; 12(2):. PubMed ID: 31979305
[TBL] [Abstract][Full Text] [Related]
12. Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men.
Bérubé-Parent S; Pelletier C; Doré J; Tremblay A
Br J Nutr; 2005 Sep; 94(3):432-6. PubMed ID: 16176615
[TBL] [Abstract][Full Text] [Related]
13. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study.
Thielecke F; Rahn G; Böhnke J; Adams F; Birkenfeld AL; Jordan J; Boschmann M
Eur J Clin Nutr; 2010 Jul; 64(7):704-13. PubMed ID: 20372175
[TBL] [Abstract][Full Text] [Related]
15. Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions.
Gregersen NT; Bitz C; Krog-Mikkelsen I; Hels O; Kovacs EM; Rycroft JA; Frandsen E; Mela DJ; Astrup A
Br J Nutr; 2009 Oct; 102(8):1187-94. PubMed ID: 19445822
[TBL] [Abstract][Full Text] [Related]
16. Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group.
Johnson KP; Brooks BR; Ford CC; Goodman A; Guarnaccia J; Lisak RP; Myers LW; Panitch HS; Pruitt A; Rose JW; Kachuck N; Wolinsky JS
Mult Scler; 2000 Aug; 6(4):255-66. PubMed ID: 10962546
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women.
Most J; Penders J; Lucchesi M; Goossens GH; Blaak EE
Eur J Clin Nutr; 2017 Sep; 71(9):1040-1045. PubMed ID: 28589947
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
Herges K; Millward JM; Hentschel N; Infante-Duarte C; Aktas O; Zipp F
PLoS One; 2011; 6(10):e25456. PubMed ID: 22022398
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ; Miller DH; Phillips JT; Hutchinson M; Havrdova E; Kita M; Yang M; Raghupathi K; Novas M; Sweetser MT; Viglietta V; Dawson KT;
N Engl J Med; 2012 Sep; 367(12):1087-97. PubMed ID: 22992072
[TBL] [Abstract][Full Text] [Related]
20. Effect of tea catechins with caffeine on energy expenditure in middle-aged men and women: a randomized, double-blind, placebo-controlled, crossover trial.
Katada S; Yanagimoto A; Matsui Y; Hibi M; Osaki N; Kobayashi S; Katsuragi Y
Eur J Nutr; 2020 Apr; 59(3):1163-1170. PubMed ID: 31062079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
